A Nanovaccine Based on Adjuvant Peptide FK‐13 and l‐Phenylalanine Poly(ester amide) Enhances CD8(+) T Cell‐Mediated Antitumor Immunity

Cancer vaccines have shown promise as effective means of antitumor immunotherapy by inducing tumor antigen‐specific T cell immunity. In this study, a novel peptide‐based tumor nanovaccine that boosts antigen presentation and elicits effective antitumor immunity is developed. The adjuvant characteris...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Chunyuan, You, Xinru, Zhang, Hongxia, Li, Jiahui, Wang, Liying, Liu, Yongxiang, Wang, Zining, Yao, Ruhui, Tong, Tong, Li, Mengyun, Wang, Xiaojuan, Cui, Lei, Zhang, Huanling, Guo, Hui, Li, Chunwei, Wu, Jun, Xia, Xiaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369282/
https://www.ncbi.nlm.nih.gov/pubmed/37162249
http://dx.doi.org/10.1002/advs.202300418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369282/
https://www.ncbi.nlm.nih.gov/pubmed/37162249
http://dx.doi.org/10.1002/advs.202300418

Ejemplares similares